Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02748148
Other study ID # MTM-309
Secondary ID
Status Completed
Phase N/A
First received April 1, 2016
Last updated October 14, 2016
Start date April 2016
Est. completion date September 2016

Study information

Verified date October 2016
Source Tabula Rasa HealthCare
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.


Description:

The specific aim of this study is to implement a Medication Therapy Management (MTM) service in primary care that is enhanced by the incorporation of pharmacogenomics (PGx) and medication risk mitigation (MRM) factor technology and is standardized by a systematic approach to evidence- and personalized-based medicine. The primary objective is to implement the systematic approach to delivering an enhanced MTM service in a primary care setting. Secondary objectives include: determine how successful the communication between prescriber and pharmacist is within implementing the service, determine how PGx testing can be incorporated into primary care prescribers' daily work flow, determine if patients are receptive to PGx testing, determine how satisfied prescribers are with an enhanced MTM clinical service and their confidence to conduct on their own, and determine if enhanced MTM optimizes or changes drug therapy for patients.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Receiving primary health care from Elmwood Family Physicians; and

- Medicare beneficiary; and

- Currently prescribed at least 7 medications, or prescriber feels patient would benefit from enhanced medication therapy management, or actual or suspected medication-related problem

Exclusion Criteria:

- Not willing to participate in the study and sign informed consent; or

- Non-English speaking or designated surrogate as translator not available

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Other:
Medication therapy management
Implementation of a systematic approach to evidence- and personalized-based medicine through a pharmacist-guided medication therapy management service

Locations

Country Name City State
United States Elmwood Family Physicians Marlton New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Tabula Rasa HealthCare

Country where clinical trial is conducted

United States, 

References & Publications (6)

Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med. 2007 Dec 4;147(11):755-65. — View Citation

Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997 Jan 22-29;277(4):301-6. — View Citation

Doan J, Zakrzewski-Jakubiak H, Roy J, Turgeon J, Tannenbaum C. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother. 2013 Mar;47(3):324-32. doi: 10.1345/aph.1R621. Epub 2013 Mar 12. — View Citation

Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9. — View Citation

Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999 Oct 15;286(5439):487-91. Review. — View Citation

Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008 Jul;42(7):1017-25. doi: 10.1345/aph.1L037. Epub 2008 Jul 1. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Qualitative description of process-related challenges and successes as assessed by observation and survey Implementation 3 months No
Secondary Quantitative description of bidirectional communication as assessed by turn-around times from pharmacist's recommendations delivered to prescriber's responses received Communication 3 months No
Secondary Qualitative description of incorporation of pharmacogenomic testing into workflow and receptiveness as assessed by observation and survey Pharmacogenomic testing 3 months No
Secondary Qualitative description of prescriber satisfaction with enhanced medication therapy management services as assessed by survey Prescriber survey 3 months No
Secondary Qualitative and quantitative description of potential impact of enhanced medication therapy management services on drug regimens as assessed by before-and-after observations Impact 3 months No
See also
  Status Clinical Trial Phase
Completed NCT02816086 - A New Interdisciplinary Collaboration Structure to Improve Medication Safety in the Elderly N/A
Withdrawn NCT04893395 - Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans N/A
Completed NCT02562352 - Team Approach to Polypharmacy Evaluation and Reduction N/A
Completed NCT02863341 - Nursing Home Team-Care Deprescribing Study N/A
Completed NCT01970774 - Medication Therapy Management With Pharmacogenetic Testing N/A
Completed NCT04151797 - Impact of a Mobile Geriatric Team With a Pharmacist on the Optimisation of Prescriptions in Elderly Inpatients N/A
Enrolling by invitation NCT06383364 - The Effect of a Medication Coordinator on the Quality of Patients Medication Treatment N/A
Completed NCT03154489 - Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care N/A
Completed NCT03257605 - A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly N/A
Not yet recruiting NCT06310512 - Efficacy of Pharmacist Interventions Through the "Medication Therapy Management Pathway in Hypertensive Patients" N/A
Recruiting NCT02942927 - Team Approach to Polypharmacy Evaluation and Reduction N/A
Completed NCT03909035 - A Collaborative Approach to Medication Reviews for Older Patients With Polypharmacy N/A
Recruiting NCT03557944 - Team Approach to Polypharmacy Evaluation and Reduction (Pharmacy) N/A
Completed NCT02820129 - Effectiveness of a Medication Wallet Card Phase 1
Terminated NCT03202264 - Team Approach to Polypharmacy Reduction to Improve Mobility Long-Term Care
Completed NCT03321058 - Polymedication-Check With Insight in Patients' Medication Organisation and Comprehension of Generics N/A
Completed NCT02658604 - Home Medication Reviews by Pharmacists in Ontario, Canada N/A
Withdrawn NCT05711771 - Medication Therapy Management (MTM) for a Medicaid Managed Care Population Within Patient-Centered Medical Homes
Recruiting NCT05553015 - A Real-World Registry Investigating TReprostInil sodiUM in Pulmonary Hypertension (Re-TRIUMPH)
Active, not recruiting NCT05278650 - Senior PharmAssist: Co-Design and Evaluation of a Toolkit to Promote Scalable Implementation N/A